As the prevalence of cardiovascular disease (CVD) continues to grow, Rhys Tassell, Point of Care Testing Team Lead at Cambridge University Hospitals NHS Foundation Tr...

Getting the right medicine into the hands of a patient in a timely manner has always been the ultimate goal in the clinical supply chain, as Neil Sherman, Technical S...

In this article, Sarah Ray, Senior Research Analyst, explores the following issue: amidst a regulatory environment which increasingly focuses on evidence-based resear...

A Two-step Pre-screening Process Before Site Referral Improves Efficiency and Reduces Costs  Clinical trial recruitment involves three distinct phases: (1) Connecting...

According to this article from Charlotte Housden, Head of the Biotechnology and Research Business Unit at Cambridge Cognition, there is increasing pressure on pharmac...

Riin Ehin, Chairwoman of the Board and CEO of Competence Centre for Cancer Research, partner and CEO of Bravo Healthcare Ltd., submits a paper on endometrial cancer. ...

As Markku Toivonen, MD, PhD, chairman of CHMP Scientific Advice Working Party, explains in this piece, according to current evidence, Alzheimer’s disease (AD) is a di...

Mona Dawood, Head of the Pharmaceutical Operations & Regulatory Affairs for CIDP Group, provides an insightful report on Singapore, a fascinating country full of ...

With the growth of comparative effectiveness research (CER) and the need for large volumes of active comparator medicines comes an increased demand for effective sour...

Each year, Veeva surveys the pharmaceutical industry on its use of trial master file (TMF) processes. Within this article, Rik van Mol, Vice President of R&D Stra...